We are engaged in the “bidirectional translational research” to solve clinical problems in intractable diseases including cancers and immune disorders. Following research projects are currently in progress.
- Development and clinical application of a new inflammatory biomarker, LRG
- Search for new therapeutic targets of autoimmune disorders through the consortium-based collaboration with other academia and industries.
- Clinical application of SOCS, a family of cytokine signaling inhibitors, as a novel gene therapy for cancers.
- Identification of new cancer antigens and development of antibody-based therapy for cancers.
Detailed information is available at:
URL: http://www.kochi-u.ac.jp/kms/rinme/（Coming Soon）